Using transgenic mice to analyze the mechanisms of progression of chronic renal failure.
An understanding of the mechanisms underlying the formation of renal lesions is necessary for the development of strategies aiming to delay the progression of chronic renal failure. The generation of transgenic mice in the past 20 years has contributed significantly to the study of this phenomenon. Overexpression and/or inactivation of single factors in renal tissue demonstrated that molecules such as growth factors, proto-oncogenes, and renin-angiotensin system elements play major roles in renal deterioration. Several mouse models of renal injury have been developed in the past 10 yr. Transgenic mice that exhibit a normal phenotype under physiologic conditions allow analysis of the roles of single factors in the progression of chronic renal failure when renal injury models are used. Using this strategy, it was demonstrated that vascular adaptation, which is a process that involves the endothelin/nitric oxide balance, is essential for the survival of mice after nephron reduction and that the epidermal growth factor/activator protein-1/Bcl-2 pathway is involved in the development of renal lesions after renal injury, possibly via adjustment of the proliferation/apoptosis balance. Moreover, it was demonstrated that selective inhibition of epidermal growth factor signaling in the kidney successfully prevents the progression of chronic renal failure. These results indicate the power of transgenesis for elucidation of the pathogenesis of renal disease.
Terzi
F
F
INSERM U426 and Department of Physiology, Xavier Bichat Medical School, Paris 7 University, Paris, France. terzi@cochin.inserm.fr
Burtin
M
M
Friedlander
G
G
D000222:Adaptation, Physiological; D000818:Animals; D018450:Disease Progression; D004815:Epidermal Growth Factor / Q000502:physiology; D006439:Hemodynamics; D007668:Kidney / Q000254:growth & development / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000235:genetics / Q000473:pathology / Q000503:physiopathology*; D051379:Mice; D018345:Mice, Knockout / Q000235:genetics; D008822:Mice, Transgenic / Q000235:genetics; D009392:Nephrectomy; D014746:Vimentin / Q000235:genetics
D014746:Vimentin; D004815:Epidermal Growth Factor